Controlled Ovarian Hyperstimulation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Controlled Ovarian Hyperstimulation trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05173597

Real-world Evidence on Follitropin Delta Individual Dosing

As part of the in vitro fertilisation treatment, ovarian stimulation is routinely performed. For this purpose, FSH preparations are used. Follitropin delta is a…

Germany850 participantsStarted 2021-12-08

Treatment: Follitropin delta

All recent trials (68 shown)

CompletedNot Applicable

NCT07568886

Albumin and Furosemide for Preventing Ovarian Hyperstimulation Syndrome in ICSI Patients

This study aims to evaluate whether the combination of Albumin and Furosemide can reduce the risk of Ovarian Hyperstimulation Syndrome in women undergoing intra…

Iraq200 participantsStarted 2019-04-29

Treatment: Albumin (Human) 20%, Furosemide

CompletedPhase 4

NCT02892942

NATural Ovarian Stimulation

To overcome unsuitable effects of controlled ovarian hyperstimulation (COH )while maintaining large oocyte availability, investigators elaborated an innovative…

France129 participantsStarted 2017-01-13

Treatment: Gonal-F®, Cetrotide®

Controlled Ovarian Hyperstimulation

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Real-world Evidence on Follitropin Delta Individual Dosing

All recent trials (68 shown)

Albumin and Furosemide for Preventing Ovarian Hyperstimulation Syndrome in ICSI Patients

NATural Ovarian Stimulation

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Real-world Evidence on Follitropin Delta Individual Dosing

All recent trials (68 shown)

Albumin and Furosemide for Preventing Ovarian Hyperstimulation Syndrome in ICSI Patients

NATural Ovarian Stimulation

Serum FSH Levels During Controlled Ovarian Stimulation

Identify Effective Doses of LY01021 in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted…

To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subject…

Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome

Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders

A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa)…

Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol f…

Comparison of Two PPOS Models for Pituitary Suppression

Identify Effective Doses of SHR7280 Tablets in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing…

Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures

Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome

Luteal Phase Progesterone in IUI and Gonadotropin Cycles

Monitor the Incidence of Congenital Malformations in Infants of Women Who Have Been Treated With Ganirelix (Orgalutran®)…

Growth Hormone Adding to Controlled Ovarian Hyperstimulation for Improving Embryo Quality

Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment

The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome

Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders

Controlled Ovarian Hyperstimulation (COH) With Sequential HPFSH & HMG Versus Rec-F.S.H Alone in ICSI Cycle